BIOMAT Database Logo BIOMAT Database Logo

[Hepatic elimination of indocyanine green and antipyrine in patients with chronic liver disease]. 1982

H D Kuntz, and D Meessen, and B May

UI MeSH Term Description Entries
D007208 Indocyanine Green A tricarbocyanine dye that is used diagnostically in liver function tests and to determine blood volume and cardiac output. Cardio-Green,Cardiogreen,Ujoveridin,Vofaverdin,Vophaverdin,Wofaverdin,Cardio Green,Green, Indocyanine
D008107 Liver Diseases Pathological processes of the LIVER. Liver Dysfunction,Disease, Liver,Diseases, Liver,Dysfunction, Liver,Dysfunctions, Liver,Liver Disease,Liver Dysfunctions
D008111 Liver Function Tests Blood tests that are used to evaluate how well a patient's liver is working and also to help diagnose liver conditions. Function Test, Liver,Function Tests, Liver,Liver Function Test,Test, Liver Function,Tests, Liver Function
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D006505 Hepatitis INFLAMMATION of the LIVER. Hepatitides
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000983 Antipyrine An analgesic and antipyretic that has been given by mouth and as ear drops. Antipyrine is often used in testing the effects of other drugs or diseases on drug-metabolizing enzymes in the liver. (From Martindale, The Extra Pharmacopoeia, 30th ed, p29) Phenazone,Anodynin,Pyramidone

Related Publications

H D Kuntz, and D Meessen, and B May
Hepatic clearances of antipyrine, indocyanine green, and galactose in normal subjects and in patients with chronic liver diseases.
August 1988, Clinical pharmacology and therapeutics,
H D Kuntz, and D Meessen, and B May
Antipyrine elimination and hepatic microsomal enzyme activity in patients with liver disease.
June 1990, Clinical pharmacology and therapeutics,
H D Kuntz, and D Meessen, and B May
Indocyanine green elimination in patients with liver disease and in normal subjects.
February 1991, Clinical science (London, England : 1979),
H D Kuntz, and D Meessen, and B May
Major determinants of drug disposition in chronic liver disease: a study with indocyanine green and antipyrine [proceedings].
August 1975, British journal of clinical pharmacology,
H D Kuntz, and D Meessen, and B May
The clearance of antipyrine and indocyanine green in normal subjects and in patients with chronic lever disease.
July 1976, Clinical pharmacology and therapeutics,
H D Kuntz, and D Meessen, and B May
Antipyrine, paracetamol, and lignocaine elimination in chronic liver disease.
May 1977, British medical journal,
H D Kuntz, and D Meessen, and B May
Antipyrine, oxazepam, and indocyanine green clearance in patients with chronic pancreatitis and healthy subjects.
August 1999, Scandinavian journal of gastroenterology,
H D Kuntz, and D Meessen, and B May
Effect of aging and cigarette smoking on antipyrine and indocyanine green elimination.
July 1979, Clinical pharmacology and therapeutics,
H D Kuntz, and D Meessen, and B May
[Liver capacity in the biotransformation of drugs in patients with chronic circulatory failure (kinetics of antipyrine and indocyanine green)].
October 1978, Polskie Archiwum Medycyny Wewnetrznej,
H D Kuntz, and D Meessen, and B May
[Hepatic extraction of taurocholate and indocyanine green in patients with liver disease (author's transl)].
November 1979, Zeitschrift fur Gastroenterologie,
Copied contents to your clipboard!